Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Gossamer Bio, Inc.

NASDAQ: GOSS · Life Sciences · 6 alerts · CIK 1728117

Share price
$10.98Close, Nov 16
Market cap
$67.2M
Shares outstanding
6.12MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Gossamer Bio, Inc. filings on SEC EDGAR ↗

4:02 PM ET 8-K
Capital Raise

Gossamer Bio Capital Raise

Gossamer Bio stockholders approved the potential issuance of common stock exceeding 20% of outstanding shares in connection with a Securities Purchase Agreement dated August 20, 2026. The approval covers shares issuable upon the exercise of Pre-Funded Warrants, FDA Approval Warrants, and the conversion of Series A-1, A-2, and A-3 Preferred Stock, satisfying Nasdaq Listing Rules 5635(c) and 5635(d).

4:02 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Gossamer Bio Nasdaq/NYSE Compliance Notice

Gossamer Bio has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, resolving a deficiency notice originally received on April 8, 2026. The company achieved compliance following a 1-for-80 reverse stock split that became effective on September 10, 2026, and the matter is now closed.

Counterparty
The Nasdaq Stock Market LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.